MARLBOROUGH, Mass., May 8, 2024
/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced
today the election of Dr. Cheryl
Pegus to its board of directors, effective immediately.
Dr. Pegus has more than 25 years of clinical and business
leadership experience, most recently serving as a partner at Morgan
Health focused on improving the quality, affordability and equity
of health care. Prior to that, Dr. Pegus was executive vice
president of Health & Wellness at Walmart, president of
Consumer Solutions and chief medical officer for Cambia Health
Solutions and chief medical officer at Walgreens. Before joining
Walgreens, Dr. Pegus was the general manager and chief medical
officer for SymCare Personalized Health Solutions, Inc., a
diabetes-focused division of Johnson & Johnson, and held roles
at Pfizer and Aetna.
Dr. Pegus began her career in private practice as a cardiologist
and previously served as board chair for the Association of Black
Cardiologists. She serves on the board of the American Heart
Association and is co-founder of A New Beat, an organization
dedicated to improving the cardiovascular health and careers of
women and underrepresented minorities. Dr. Pegus received her B.A.
from Brandeis University, her M.D. from
Weill Cornell Medical College and her M.P.H. from Columbia University Mailman School of Public
Health.
"We are pleased to expand our board of directors with a highly
respected, visionary clinical leader," said Mike Mahoney, chief executive and chairman of
the board, Boston Scientific. "Cheryl is passionate about the role
health care innovation can play in improving outcomes and expanding
health care access, and we look forward to her contributions as
Boston Scientific continues to grow and serve more patients around
the world."
About Boston Scientific
Boston Scientific transforms lives through innovative medical
technologies that improve the health of patients around the world.
As a global medical technology leader for more than 40 years, we
advance science for life by providing a broad range of
high-performance solutions that address unmet patient needs and
reduce the cost of healthcare. Our portfolio of devices and
therapies helps physicians diagnose and treat complex
cardiovascular, respiratory, digestive, oncological, neurological
and urological diseases and conditions. Learn more
at www.bostonscientific.com and connect
on LinkedIn and X, formerly
Twitter.
CONTACTS
|
|
Media:
|
Investors:
|
Emily
Anderson
|
Jon Monson
|
617-515-2000
(office)
|
508-683-5450
(office)
|
Media
Relations
|
Investor
Relations
|
Boston Scientific
Corporation
|
Boston Scientific
Corporation
|
Emily.Anderson2@bsci.com
|
BSXInvestorRelations@bsci.com
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/boston-scientific-elects-dr-cheryl-pegus-to-board-of-directors-302140322.html
SOURCE Boston Scientific Corporation